Cytologic evidence for gene amplification in methotrexate-resistant cells obtained from a patient with ovarian adenocarcinoma.
about
DHFR/MSH3 amplification in methotrexate-resistant cells alters the hMutSalpha/hMutSbeta ratio and reduces the efficiency of base-base mismatch repairAdvances in pharmacogenetics and pharmacogenomics.Overlooking evolution: a systematic analysis of cancer relapse and therapeutic resistance research.Frequencies of independent and simultaneous selection of Chinese hamster cells for methotrexate and doxorubicin (adriamycin) resistanceDeterminants of the sensitivity of human small-cell lung cancer cell lines to methotrexate.The emergence of resistance to targeted cancer therapeutics.Autoantibody signature for the serologic detection of ovarian cancerResistance to antifolates.Clinical relevance of P-glycoprotein in drug therapy.Cancer research meets evolutionary biology.Fifth Gordon Hamilton-Fairley memorial lecture. Methotrexate resistance and gene amplification: an experimental model for the generation of cellular heterogeneityMechanisms of antifolate resistance and methotrexate efficacy in leukemia cells.Elimination of extrachromosomally amplified MYC genes from human tumor cells reduces their tumorigenicity.Gene amplification: an example of accelerated evolution in tumorigenic cellsNormal diploid human and rodent cells lack a detectable frequency of gene amplification.Human myeloma cells acquire resistance to difluoromethylornithine by amplification of ornithine decarboxylase gene.Cancer chemotherapy: targeting folic acid synthesis.Mechanism of methotrexate-sensitivity of choriocarcinoma cells in culture.Molecular analysis of gene amplification in tumors.
P2860
Q28610848-4A873E67-33BA-451F-A7D8-51683CA4FF81Q34024117-D631C999-F153-472C-B2DD-E5154D696483Q34085685-6AF0C7EE-2C93-43D3-AA65-ADC6C191732EQ34381440-D0B9EB7E-4214-4B8D-BCEF-6489B01C188AQ34557626-DA0826A5-CBA8-4BF8-B3D5-42E836170F83Q34837015-A8F01FF8-8D39-4CC4-8549-0E7D052A47C3Q35100846-D55FE288-28EB-46F0-B22D-F1D37C09C1A1Q35567272-F3FD9A7E-DAD7-4C25-AC18-3FD8801EDF88Q35620664-D9CAA96F-97A3-4003-AC6C-7628DAF739A8Q35960758-C51CDC1D-DFD9-4AB9-890D-997F738D33C5Q35992354-CE2EE07A-9BBD-4566-8DB3-A2200E6268CAQ37093674-6CA8BD63-03B4-47E0-B31F-E839889C7121Q37181608-BD058F83-E957-43A8-86FE-0CAC6B966B40Q37552193-0675832E-9A41-4A37-87EE-71663450CE98Q37742113-E79C6022-AEF0-44B9-BD85-D8AC3BD7C98CQ41768853-DEAAB598-3E4C-4F6D-AB2A-C6DA6717DF51Q42588769-279E7005-15C0-499C-92B2-60C91B7C9614Q43528645-69A53A5A-B2A2-4874-A8A6-8E5D0B7F3C99Q54536070-B893FA77-BC49-403C-A685-9AA466386BCA
P2860
Cytologic evidence for gene amplification in methotrexate-resistant cells obtained from a patient with ovarian adenocarcinoma.
description
1984 nî lūn-bûn
@nan
1984 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1984 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
name
Cytologic evidence for gene am ...... t with ovarian adenocarcinoma.
@ast
Cytologic evidence for gene am ...... t with ovarian adenocarcinoma.
@en
Cytologic evidence for gene am ...... t with ovarian adenocarcinoma.
@nl
type
label
Cytologic evidence for gene am ...... t with ovarian adenocarcinoma.
@ast
Cytologic evidence for gene am ...... t with ovarian adenocarcinoma.
@en
Cytologic evidence for gene am ...... t with ovarian adenocarcinoma.
@nl
prefLabel
Cytologic evidence for gene am ...... t with ovarian adenocarcinoma.
@ast
Cytologic evidence for gene am ...... t with ovarian adenocarcinoma.
@en
Cytologic evidence for gene am ...... t with ovarian adenocarcinoma.
@nl
P2093
P356
P1476
Cytologic evidence for gene am ...... t with ovarian adenocarcinoma.
@en
P2093
P356
10.1200/JCO.1984.2.1.8
P407
P577
1984-01-01T00:00:00Z